IP Library Granted Patent US 8,277,848
Granted Patent B2
US 8,277,848 · App. 13/185,634 · Granted Oct 2, 2012

Method for preparing aqueous solution of high-concentration calcium phosphate stable in neutral pH range

Assignee: Bioalpha Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,277,848
App. No.
13/185,634
Granted
Oct 2, 2012
Kind
B2
Abstract

Disclosed herein is a method for preparing an aqueous solution of high-concentration calcium phosphate, the method comprising the steps of: preparing an acidic aqueous solution using an acidic chelating agent; and dissolving a calcium phosphate-based compound in the acidic aqueous solution, and then adding a pH-adjusting agent to the acidic aqueous solution to adjust the pH of the acidic aqueous solution. The disclosed aqueous solution does not form a precipitate after neutralization so that it can be used in various calcium-containing products, including foods, drugs, or quasi-drugs.

Claims (14)

1. A method for preparing an aqueous solution of high-concentration calcium phosphate, the method comprising the steps of:

preparing an acidic aqueous solution using an acidic chelating agent;

dissolving a calcium phosphate-based compound in the acidic aqueous solution to obtain an aqueous calcium phosphate solution; and

adding a pH-adjusting agent to the aqueous calcium phosphate solution increase the pH of the aqueous solution.

2. The method of claim 1 , wherein phosphoric acid (H 3 PO 4 ) is further added to the aqueous calcium phosphate solution.

3. The method of claim 1 , wherein the acidic chelating agent is any one selected from citric acid and EDTA (ethylene diamine tetra-acetic acid).

4. The method of claim 1 , wherein the calcium phosphate-based compound is at least one selected from the group of hydroxyapatite, carbonated apatite Ca 10 , tricalcium phosphate, and calcium hydrogen phosphate.

5. The method of claim 1 , wherein the pH-adjusting agent is at least one selected from sodium hydroxide and sodium hydrogen carbonate.

6. The method of claim 1 , wherein the acidic aqueous solution and the calcium phosphate-based compound are an aqueous citric acid solution and nano-sized carbonated apatite (n-CAP), respectively.

7. The method of claim 6 , wherein the citric acid and the n-CAP are used at concentrations of 0.3 wt % or less and 0.25 wt % or less, respectively, based on the total weight of the aqueous calcium phosphate solution.

8. The method of claim 6 , wherein the citric acid and the n-CAP are used at concentrations of 0.1 wt %, respectively, based on the total weight of the aqueous calcium phosphate solution.

9. The method of claim 1 , wherein the pH of the aqueous calcium phosphate solution is in the range from 5.5 to 6.1.

10. The method of claim 2 , wherein the phosphoric acid is added in an amount of 0.0012˜0.006 wt % based on the total weight of the aqueous calcium phosphate solution.

11. The method of claim 10 , wherein the phosphoric acid is added in an amount of 0.0024 wt % based on the total weight of the aqueous calcium phosphate solution.

Assignments (3)
MERGER Recorded Sep 2, 2021
From: BIOALPHA CORPORATION
To: CG BIO CO., LTD.
Reel/Frame 057364/0551 →
CHANGE OF ADDRESS Recorded Sep 2, 2021
From: BIOALPHA CORPORATION
To: BIOALPHA CORPORATION
Reel/Frame 057395/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2011
From: RYU, HYUN SEUNG; RYU, MI YOUNG; SEO, JUN HYUK; JANG, GYU DONG; KIM, BAEK IL
To: BIOALPHA INC.
Reel/Frame 026648/0553 →
Priority Claims (1)
KR 10-2011-0004956 · Jan 18, 2011 · national
Continuity (1)
Related Publication 20120183625A1 · Jul 19, 2012